Influence of XPG mRNA levels on the effect of BRCA1 mRNA levels in prognosis of early non-small cell lung cancer (NSCLC)

被引：1
|
作者：
Bartolucci, R.
Botia, M.
Mendez, P.
Puma, F.
Sabatini, S.
Catanzani, S.
Urbani, M.
Saccenti, P.
Taron, M.
Rosell, R.
机构：
[1] Azienda Osped, Terni, Italy
[2] ICO Hosp Germans Trias & Pujol, Badalona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.7545
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7545
引用
收藏
页数：1
相关论文
共 50 条
  • [11] CUSTOMIZING ADJUVANT CHEMOTHERAPY BASED ON BRCA1 MRNA LEVELS IN RESECTED STAGE II-IIIA NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (P)
    Moran, T.
    Massuti, B.
    Jimenez, U.
    Aguiar, D.
    Carrato, A.
    Lopez-Vivanco, G.
    Maestu, I.
    Camps, C.
    Oramas, J.
    Rosell, R.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 92 - 93
  • [12] Outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) according to the presence of the EGFR T790M mutation and BRCA1 mRNA expression levels in pretreatment biopsies
    Rosell, R.
    Molina, M. A.
    Costa, C.
    Taron, M.
    Bertran-Alamillo, J.
    Mayo, C.
    Benlloch, S.
    Moran, T.
    Cardenal, F.
    Porta, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [13] Bio-ANITA project: increased BRCA1 mRNA levels predict favorable outcome in non-small cell lung cancer (NSCLC) patients receiving adjuvant cisplatin (cis)/vinorelbine (vrb)
    Wei, Jia
    Okamoto, Tatsuro
    Sanchez-Ronco, Maria
    Chaib, Imane
    Perez-Roca, Laia
    Mendez, Pedro
    Taron, Miquel
    Liu, Baorui
    Rosell, Rafael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S298 - S299
  • [14] IMPACT OF XANTHINE OXIDOREDUCTASE AND BRCA1 ON PROGNOSIS OF ADVANCED NON-SMALL CELL LUNG CANCER
    Yalcin, Selim
    Kucukoztas, Nadire
    Rahatli, Samed
    Dizdar, Omer
    Kilic, Dalokay
    Altundag, Ozden
    Abali, Huseyin
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1174 - S1174
  • [15] Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients
    Yuan, A
    Yu, CJ
    Shun, CT
    Luh, KT
    Kuo, SH
    Lee, YC
    Yang, PC
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2005, 115 (04) : 545 - 555
  • [16] Increased BRCA1 mRNA: An independent prognostic variable in completely resected chemo-naive non-small cell lung cancer (NSCLC) patients (p)
    Rosell, R.
    Jassem, E.
    Skrzypski, M.
    Taron, M.
    Mendez, P.
    Perez, L.
    Szymanowska, A.
    Rzyman, W.
    Gulida, G.
    Jassem, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [17] Serum carcirmembryonic antigen (CEA) levels a NB prognosis in early and advanced non-small cell lung cancer (NSCLC)
    Cedres Perez, S.
    Nunez, I.
    Longo, M.
    Martinez, P.
    Rodriguez Checa, E.
    Cazorla, M.
    Felip, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [18] Predictive role of RRM1 and BRCA1 mRNA expression on the clinical outcome of advanced non-small cell lung cancer
    Liang, J. G.
    Jin, Z. Y.
    Gao, X. D.
    Te, M. R.
    Ge, L. H.
    Wang, C. L.
    [J]. GENETICS AND MOLECULAR RESEARCH, 2014, 13 (03) : 5292 - 5298
  • [19] Increased expression levels of human telomerase reverse transcriptase (hTERT) mRNA correlates with poor prognosis in resected non-small cell lung cancer (NSCLC) patients
    Carrera, S.
    Lopez-Vivanco, G.
    Calvo, B.
    Aresti, U.
    Jangi, M. S.
    Ferreiro, J.
    Martinez-Bueno, A.
    Rubio, I.
    Munoz, A.
    Ancizar, N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [20] ODC mRNA expression in curatively resected non-small cell lung cancer (NSCLC)
    Grimminger, Peter P.
    Danenberg, Peter V.
    Daniel, Vallboehmer
    Schneider, Paul M.
    Hoelscher, Arnulf H.
    Brabender, Jan
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : S239 - S239
12345